US Stock MarketDetailed Quotes

TVTX Travere Therapeutic

Watchlist

22.910
-0.810-3.41%

Close Feb 14 16:00 ET

24.000
+1.090+4.76%

Post 20:01 ET

1.99BMarket Cap-5.00P/E (TTM)

Travere Therapeutic Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Travere Therapeutic Q4 2024 Estimates Date

Currency：USDFeb 20, 2025

	Estimate	YoY
Revenue	72.38M	+60.62%
EPS	-0.57	+51.78%

Analyst Rating

Strong Buy

Feb 16, 2025

Travere Therapeutic Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 72.679M	--
Feb 20, 2025	2024/Q4	-- / 72.375M	--
Oct 31, 2024	2024/Q3	62.898M / 60.831M	--
Aug 1, 2024	2024/Q2	54.116M / 52.686M	--
May 6, 2024	2024/Q1	41.374M / 43.616M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 72.679M--

Feb 20, 20252024/Q4-- / 72.375M--

Oct 31, 20242024/Q362.898M / 60.831M--

Aug 1, 20242024/Q254.116M / 52.686M--

May 6, 20242024/Q141.374M / 43.616M--

Unlock Free Earnings Estimates

Open Account

Travere Therapeutic Earnings Reports

Travere Therapeutic | 10-Q: Q3 2024 Earnings Report

Oct 31, 2024 08:41 ET

Travere Therapeutic | 8-K: Travere Therapeutics Reports Third Quarter 2024 Financial Results

Oct 31, 2024 08:06 ET

Travere Therapeutic | 10-Q: Q2 2024 Earnings Report

Aug 1, 2024 16:42 ET

Travere Therapeutic | 8-K: Travere Therapeutics Reports Second Quarter 2024 Financial Results

Aug 1, 2024 16:07 ET